Treatment with TNF inhibitors such as antibodies (e.g. infliximab) or TNF blockers (e.g. etanercept) effectively ameliorates inflammation, but there is currently no cure for ORAS. The gene discussed is TNF; the disease is autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive.